Mycophenolate mofetil (MMF) has been used successfully as an immunosuppressive medication in transplantation for over a decade. Owing to its efficacy and relatively benign adverse effect profile ...

The use of mycophenolate mofetil (MMF) for prophylaxis of aGVHD and/or for treatment of acute or chronic GVHD is increasing. However, the benefit of MMF as an alternative to commonly used ...

The mycophenolate mofetil group had fewer treatment failures than the glucocorticoid-only group (22% [13 of 59 patients] vs. 44% [27 of 61 patients]; hazard ratio, 0.41; range, 0.21 to 0.80 ...

Maintenance therapy, often with azathioprine or mycophenolate mofetil, is required to consolidate remission and prevent relapse after the initial control of lupus nephritis. We carried out a 36 ...

† One patient had MMF as an initial treatment. ‡ In the study TAC and MMF were used alone or in combination. §In total, 17 patients were initially treated with MMF and steroids. ¶ Females ...

If you continue to have this issue please contact [email protected]. Patients treated with mycophenolate mofetil were more likely to experience complete biochemical response vs.

Adding mycophenolate mofetil to a glucocorticoid in first-line treatment for immune thrombocytopenia improves response and decreases the risk for refractory or relapsed disease, according to data.

Tacrolimus outshined another immunosuppressive drug at extending relapse-free survival in kids with frequently relapsing or steroid-dependent nephrotic syndrome in a randomized study from China. All ...

Background: The Mycophenolate Steroids Sparing (MYSS) study showed that, when combined with ciclosporin microemulsion, mycophenolate mofetil is not superior to azathioprine in preventing acute ...

Mycophenolate mofetil is a disease-modifying anti-rheumatic drug (DMARD) used to treat rheumatic diseases such as systemic lupus erythematosus (SLE, lupus), myositis and vasculitis. It has been ...

The immunosuppressives used to induce remission include methylprednisolone with mycophenolate mofetil, low- and high‑dose cyclophosphamide, rituximab with mycophenolate mofetil, and tacrolimus with or ...